 | Up a level |
Hughes, Carly A, Ahern, Amy L, Kasetty, Harsha, McGowan, Barbara M, Parretti, Helen M, Vincent, Ann and Halford, Jason CG 
ORCID: 0000-0003-1629-3189
(2021)
Changing the narrative around obesity in the UK: a survey of people with obesity and healthcare professionals from the ACTION-IO study.
BMJ OPEN, 11 (6).
e045616-.
Wilding, John PH ORCID: 0000-0003-2839-8404, Batterham, Rachel L, Calanna, Salvatore, Davies, Melanie, Van Gaal, Luc F, Lingvay, Ildiko, McGowan, Barbara M, Rosenstock, Julio, Tran, Marie TD, Wadden, Thomas A et al (show 4 more authors)
(2021)
Once-Weekly Semaglutide in Adults with Overweight or Obesity.
NEW ENGLAND JOURNAL OF MEDICINE, 384 (11).
pp. 989-1002.
Brown, Adrian, Dobbie, Laurence J ORCID: 0000-0003-1908-848X, Falvey, Laura, Patel, Dipesh C, Kwan, Jonathan TC, Steinmo, Siri, Chow, Ling and McGowan, Barbara M
(2024)
Real-world data of a digitally enabled, time-restricted eating weight management program in public sector workers living with overweight and obesity in the United Kingdom: A service evaluation of the Roczen program.
Obesity science & practice, 10 (1).
e730-e730.
Wilding, John PH ORCID: 0000-0003-2839-8404, Batterham, Rachel L, Davies, Melanie, Van Gaal, Luc F, Kandler, Kristian, Konakli, Katerina, Lingvay, Ildiko, McGowan, Barbara M, Oral, Tugce Kalayci, Rosenstock, Julio et al (show 4 more authors)
(2022)
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.
DIABETES OBESITY & METABOLISM, 24 (8).
pp. 1553-1564.